Staffan Lindstrand

Staffan Lindstrand currently works at Doctrin AB, as Chairman, Orexo AB, as Independent Director from 2002, Technolas Perfect Vision GmbH, as Director, Swedish Association of Exchange Listed Cos., as Director, Gerner Holdings AB, as Director, Limehold AB, as Director, Severus SA, as Director, Elsa Science AB, as Director from 2021, Pactumize AB, as Director, and HealthCap AB, as Partner from 1997.
Mr. Lindstrand also formerly worked at Aerocrine AB, as Independent Director from 1999 to 2014, Inion Oy, as Director, Pulmonx Corp., as Independent Director, Biotage AB, as Director, Resistentia Pharmaceuticals AB, as Director, Newron Sweden AB, as Director, Creative Peptides Sweden AB, as Director, Direct Conversion AB, as Non-Executive Director, 20, as Director, OxThera AB, as Director, CDC, Inc., as Director, Oscars Forskola, as Director, Healthcap 1999 GP AB, as Director, and Abb Aros Securities, Inc., as Vice President from 1986 to 1997.
Mr. Lindstrand received his graduate degree from Royal Institute of Technology.